FDA Advisory Committee Votes In Favor of Approval of GRAIL's Galleri® Multi-Cancer Early Detection Test
GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual Meeting
Blue Jay Gold Announces Closing of Private Placement With Ocean Partners for Proceeds of $3.0 Million
Ucore Receives Louisiana Air Permit Covering Full 9,600 tpa Build-Out of Its Strategic Metals Complex
QIMC Sets Out Five-Phase Plan to Test Hydrogen Extraction at Bennett Hill, Nova Scotia, on the Path to Commercialization